Marshall JL - Search Results

1

Utilization of bevacizumab in US elderly patients with colorectal cancer receiving chemotherapy.

Fu AZ, Tsai HT, Marshall JL, Freedman AN, Potosky AL. Fu AZ, et al. Among authors: marshall jl. J Oncol Pharm Pract. 2014 Oct;20(5):332-40. doi: 10.1177/1078155213507010. Epub 2013 Oct 11. J Oncol Pharm Pract. 2014. PMID: 24122849 Free PMC article.

2

Capecitabine in colorectal cancer.

Marshall JL. Marshall JL. Oncology (Williston Park). 2001 Jan;15(1 Suppl 2):41-6; discussion 46-7. Oncology (Williston Park). 2001. PMID: 11219977 Free article. Review.

3

Biologic therapy for colon cancer.

He AR, Marshall J. He AR, et al. Clin Adv Hematol Oncol. 2005 Jul;3(7):555-61. Clin Adv Hematol Oncol. 2005. PMID: 16167038 Review.

4

The role of bevacizumab as first-line therapy for colon cancer.

Marshall J. Marshall J. Semin Oncol. 2005 Dec;32(6 Suppl 9):S43-7. doi: 10.1053/j.seminoncol.2005.06.003. Semin Oncol. 2005. PMID: 16399431 Review.

5

The impact of targeted therapy on the treatment of colorectal cancer.

Marshall JL, Hwang J. Marshall JL, et al. Oncology (Williston Park). 2005 Nov;19(13 Suppl 6):19-24. Oncology (Williston Park). 2005. PMID: 16502666 Free article. Review.

6

Targeted therapy for colorectal cancer.

Hwang J, Marshall JL. Hwang J, et al. Among authors: marshall jl. Curr Opin Investig Drugs. 2006 Dec;7(12):1062-6. Curr Opin Investig Drugs. 2006. PMID: 17209523 Review.

7

Bevacizumab in the treatment of colorectal cancer.

Marshall JL. Marshall JL. Clin Adv Hematol Oncol. 2007 Jan;5(1 Suppl 1):8-9. Clin Adv Hematol Oncol. 2007. PMID: 17491585 No abstract available.

8

Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.

Saltz LB, Rosen LS, Marshall JL, Belt RJ, Hurwitz HI, Eckhardt SG, Bergsland EK, Haller DG, Lockhart AC, Rocha Lima CM, Huang X, DePrimo SE, Chow-Maneval E, Chao RC, Lenz HJ. Saltz LB, et al. Among authors: marshall jl. J Clin Oncol. 2007 Oct 20;25(30):4793-9. doi: 10.1200/JCO.2007.12.8637. J Clin Oncol. 2007. PMID: 17947727 Clinical Trial.

9

A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer.

Hecht JR, Mitchell E, Chidiac T, Scroggin C, Hagenstad C, Spigel D, Marshall J, Cohn A, McCollum D, Stella P, Deeter R, Shahin S, Amado RG. Hecht JR, et al. J Clin Oncol. 2009 Feb 10;27(5):672-80. doi: 10.1200/JCO.2008.19.8135. Epub 2008 Dec 29. J Clin Oncol. 2009. PMID: 19114685 Clinical Trial.

10

Evaluation of hypertension as a marker of bevacizumab efficacy.

Ryanne Wu R, Lindenberg PA, Slack R, Noone AM, Marshall JL, He AR. Ryanne Wu R, et al. Among authors: marshall jl. J Gastrointest Cancer. 2009;40(3-4):101-8. doi: 10.1007/s12029-009-9104-9. J Gastrointest Cancer. 2009. PMID: 19921473 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

435 results

Search Page